Company Number: 12931984

Analysis Date: 2025-07-29 12:56 UTC

1. Risk Rating: HIGH
   The financial data presents significant concerns regarding solvency and liquidity. The company’s cash balance is minimal (£147), barely covering current liabilities (£49), resulting in negligible net current assets (£98). Shareholders’ funds remain static and extremely low (£100), with a loss reflected in retained earnings (-£2), indicating no accumulated profit or equity cushion. The absence of employees and lack of operating income or detailed profit and loss information suggest operational inactivity or minimal business activity, raising questions about sustainability.

2. Key Concerns:

• Minimal Cash Reserves: The company holds only £147 in cash, which is critically low for any operational or financial contingencies.
• Lack of Operating Activity: The accounts reveal no employees and no profit & loss details, suggesting no measurable business operations or revenue generation.
• Equity and Reserves Erosion: Share capital remains at £100, with a small negative retained earnings balance, indicating losses and insufficient financial buffer.

3. Positive Indicators:

• Compliance with Filings: The company is current with both accounts and confirmation statement filings, showing regulatory compliance and governance diligence.
• Stable Director Appointments: Directors have been in place since incorporation with no reported disqualifications or governance issues.
• No Overdue Liabilities: Current liabilities are low and appear manageable within the limited cash resources.

4. Due Diligence Notes:

• Verify the company’s operational status and revenue streams given the lack of employees and profit and loss disclosures.
• Investigate whether the company is dormant or undertaking any significant transactions not reflected in the financials.
• Assess the nature of current liabilities and check for any off-balance sheet obligations or contingent liabilities.
• Review director intentions and business plans to understand future viability and capital injection prospects.